Taysha Gene Therapies, Inc. TSHA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Taysha Gene Therapies, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s asset turnover?
- Taysha Gene Therapies, Inc. (TSHA) reported asset turnover of 0× in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s asset turnover changed year-over-year?
- Taysha Gene Therapies, Inc.'s asset turnover decreased by 31.3% year-over-year, from 0× to 0×.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s asset turnover?
- Over 3 years (2022 to 2025), Taysha Gene Therapies, Inc.'s asset turnover has grown at a 38.2% compound annual growth rate (CAGR), from 0× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.